✦ LIBER ✦
First-in-human study of E2609, a novel BACE1 inhibitor, demonstrates prolonged reductions in plasma beta-amyloid levels after single dosing
✍ Scribed by Robert Lai; Bruce Albala; June M. Kaplow; Jagadeesh Aluri; Mark Yen; Andrew Satlin
- Book ID
- 118468206
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 220 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1552-5260
No coin nor oath required. For personal study only.